HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chieh-I Chen Selected Research

golimumab

6/2018Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis After a Change in Targeted Therapy.
5/2017Outcomes of tumor necrosis factor inhibitor cycling versus switching to a disease-modifying anti-rheumatic drug with a new mechanism of action among patients with rheumatoid arthritis.
1/2017Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis Factor Inhibitor Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chieh-I Chen Research Topics

Disease

15Rheumatoid Arthritis
11/2019 - 01/2016
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2021 - 02/2020
5Pain (Aches)
01/2021 - 02/2014
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2021
3Fatigue
01/2018 - 01/2016
2Disease Progression
10/2022 - 01/2021
2Infections
01/2019 - 01/2019
2Necrosis
01/2019 - 01/2017
2Chronic Disease (Chronic Diseases)
01/2018 - 01/2016
2Pneumococcal Infections
07/2015 - 09/2014
1Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2022
1Skin Neoplasms (Skin Cancer)
10/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022
1Rheumatic Diseases (Rheumatism)
01/2019
1Human Influenza (Influenza)
07/2015
1Healthcare-Associated Pneumonia
05/2014
1Overactive Urinary Bladder (Overactive Bladder)
05/2014
1Complex Regional Pain Syndromes
10/2008

Drug/Important Bio-Agent (IBA)

10sarilumabIBA
11/2019 - 01/2016
9cemiplimabIBA
10/2022 - 02/2020
8Tumor Necrosis Factor InhibitorsIBA
11/2019 - 01/2016
8Antirheumatic Agents (DMARD)IBA
01/2019 - 01/2016
5Adalimumab (Humira)FDA Link
01/2019 - 01/2017
4Methotrexate (Mexate)FDA LinkGeneric
11/2019 - 01/2016
4ametantrone (HAQ)IBA
01/2019 - 01/2016
3LigandsIBA
10/2022 - 01/2021
3Abatacept (Orencia)FDA Link
06/2018 - 01/2017
3golimumabFDA Link
06/2018 - 01/2017
3tofacitinibIBA
06/2018 - 01/2017
3Infliximab (Remicade)FDA Link
06/2018 - 01/2017
3Etanercept (Enbrel)FDA Link
06/2018 - 01/2017
3tocilizumab (atlizumab)FDA Link
06/2018 - 01/2017
3Monoclonal AntibodiesIBA
01/2018 - 01/2017
2PlatinumIBA
10/2022 - 01/2021
2pembrolizumabIBA
01/2022 - 11/2021
2Certolizumab PegolFDA Link
05/2017 - 01/2017
1B7-H1 AntigenIBA
01/2022
1Chimeric Antigen ReceptorsIBA
01/2022
1Biological ProductsIBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
06/2018
1Janus Kinase InhibitorsIBA
06/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2018
1Immunoglobulins (Immunoglobulin)IBA
01/2018
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2018
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2017
1Rituximab (Mabthera)FDA Link
01/2017
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
07/2015
1Heptavalent Pneumococcal Conjugate Vaccine (Prevnar)IBA
09/2014
1Linezolid (Zyvox)FDA Link
05/2014
1VancomycinFDA LinkGeneric
05/2014
1fesoterodineFDA Link
05/2014
1Pharmaceutical PreparationsIBA
05/2014
1Ibandronic Acid (Boniva)FDA Link
10/2008

Therapy/Procedure

8Therapeutics
01/2022 - 01/2016
3Drug Therapy (Chemotherapy)
10/2022 - 01/2021
1Aftercare (After-Treatment)
01/2016
1Incontinence Pads
02/2014